loading
Schlusskurs vom Vortag:
$2.91
Offen:
$2.92
24-Stunden-Volumen:
233.11K
Relative Volume:
0.28
Marktkapitalisierung:
$383.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-7.9143
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
-6.57%
1M Leistung:
+5.11%
6M Leistung:
-20.71%
1J Leistung:
+208.33%
1-Tages-Spanne:
Value
$2.74
$2.92
1-Wochen-Bereich:
Value
$2.74
$3.03
52-Wochen-Spanne:
Value
$0.98
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
Firmenname
Compass Therapeutics Inc
Name
Telefon
617-500-8099
Name
Adresse
80 GUEST STREET, BOSTON
Name
Mitarbeiter
35
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-01
Name
Neueste SEC-Einreichungen
Name
CMPX's Discussions on Twitter

Vergleichen Sie CMPX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CMPX
Compass Therapeutics Inc
2.77 405.17M 0 -45.44M -42.28M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
376.21 96.11B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.89 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
429.20 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
668.47 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.63 33.25B 3.81B -644.79M -669.77M -6.24

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-01 Fortgesetzt Raymond James Outperform
2025-04-02 Hochstufung Leerink Partners Market Perform → Outperform
2025-02-24 Eingeleitet Guggenheim Buy
2025-02-19 Eingeleitet Piper Sandler Overweight
2024-12-23 Eingeleitet D. Boral Capital Buy
2024-11-15 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-16 Hochstufung Ladenburg Thalmann Neutral → Buy
2023-01-31 Eingeleitet Jefferies Buy
2023-01-27 Eingeleitet Stifel Buy
2022-05-23 Fortgesetzt H.C. Wainwright Buy
2022-03-15 Eingeleitet Ladenburg Thalmann Buy
2022-01-19 Eingeleitet B. Riley Securities Buy
2021-12-22 Eingeleitet Raymond James Outperform
2021-12-20 Eingeleitet SVB Leerink Outperform
2021-12-15 Eingeleitet Wedbush Outperform
Alle ansehen

Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten

pulisher
02:43 AM

Will Compass Therapeutics Inc. continue its uptrendShort Squeeze Opportunities with Indicators - Newser

02:43 AM
pulisher
01:58 AM

Has Compass Therapeutics Inc. formed a bullish divergenceChart-Based Entry Confirmation for Beginners - Newser

01:58 AM
pulisher
Aug 06, 2025

Earnings visualization tools for Compass Therapeutics Inc.Portfolio Positioning Strategy With Timing - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Compass Therapeutics Inc. stock prediction for this weekShort Term Gain Strategy with AI Logic - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

What makes Compass Therapeutics Inc. stock price move sharplyFree Consistent Gain Investment Strategies - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Is Compass Therapeutics Inc. forming a reversal patternIntraday Strategy with Real Time Monitoring - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Using Ichimoku Cloud for Compass Therapeutics Inc. technicalsAI Trend Detection for Entry Timing - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Detecting support and resistance levels for Compass Therapeutics Inc.Breakout Screener With Alert Based Timing - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Heatmap analysis for Compass Therapeutics Inc. and competitorsFree Sector Based Breakout Stock Forecast - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

What does recent volatility data suggest for Compass Therapeutics Inc.Machine Learning Intraday Signal Forecast - Newser

Aug 05, 2025
pulisher
Aug 03, 2025

Does Compass Therapeutics Inc. stock perform well during market downturnsDynamic growth stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Compass Therapeutics Inc. stock compared to the marketInvest confidently with real-time updates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Compass Therapeutics Inc.Free Expert Stock Watchlist - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Compass Therapeutics Inc. stockUnlock powerful market trend analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Compass Therapeutics Inc. in the next 12 monthsNavigate market shifts with confidence - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Compass Therapeutics Inc. stock priceAccelerated investment success - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What institutional investors are buying Compass Therapeutics Inc. stockCapitalize on momentum-driven stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is it the right time to buy Compass Therapeutics Inc. stockFree Stock Selection - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Why is Compass Therapeutics Inc. stock attracting strong analyst attentionDynamic profit expansion - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are Compass Therapeutics Inc. company’s key revenue driversMarket-leading capital gains - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is the best time to exit Compass Therapeutics Inc.Short Term Opportunity Finder with Tools - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Momentum divergence signals in Compass Therapeutics Inc. chartFree Fast Gaining Stock Screener Report - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

Price action breakdown for Compass Therapeutics Inc.Weekly Return Plan for Conservative Traders - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Using data tools to time your Compass Therapeutics Inc. exitStrong Buy Signal Summary with Entry Zone - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Can machine learning forecast Compass Therapeutics Inc. recoveryFree Low Volatility Stable Growth Picks - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Is Compass Therapeutics Inc. stock a growth or value playLong-Term Safety Investment Analysis Report - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Technical signs of recovery in Compass Therapeutics Inc.Bear Market Safe Zone Technical Analysis - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

What analysts say about Compass Therapeutics Inc. stock outlookFree AI-Powered Trade Planning with Indicators - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Why Compass Therapeutics Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Compass Therapeutics Inc. Rebound Backed by Sentiment ShiftAlpha Driven Watchlist With Alerts Published - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Can Compass Therapeutics Inc. Escape Recent Bear ChannelLow Risk High Return Opportunities Identified - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 20:25:47 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Is Compass Therapeutics Inc. a candidate for recovery playShort Term Opportunity Finder with Tools - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Compass Therapeutics Inc. Rebounds From Oversold Zone — Now WhatEarly Breakout Entry Point Notifications Sent - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What is Compass Therapeutics Inc. company’s growth strategyFree Stock Trend Scanner For 2025 - jammulinksnews.com

Jul 28, 2025

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Compass Therapeutics Inc-Aktie (CMPX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
GORDON CARL L
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
ORBIMED ADVISORS LLC
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
$77.44
price down icon 0.30%
$37.01
price down icon 0.36%
$108.66
price down icon 2.61%
$27.70
price down icon 2.89%
$111.56
price up icon 0.23%
biotechnology ONC
$295.47
price down icon 1.10%
Kapitalisierung:     |  Volumen (24h):